Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 185

1.

Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register.

Rossio R, Ardoino I, Franchi C, Nobili A, Mannuccio Mannucci P, Peyvandi F; REPOSI Investigators.

Intern Emerg Med. 2019 Aug 23. doi: 10.1007/s11739-019-02178-1. [Epub ahead of print] No abstract available.

PMID:
31444740
2.

Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients.

Carlotta F, Raffaella R, Ilaria A, Alessandro N, Mannuccio MP; REPOSI Collaborators.

Eur J Intern Med. 2019 Aug 9. pii: S0953-6205(19)30258-4. doi: 10.1016/j.ejim.2019.07.025. [Epub ahead of print] No abstract available.

PMID:
31405773
3.

Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells.

Akula SM, Candido S, Libra M, Abrams SL, Steelman LS, Lertpiriyapong K, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Matias de Alencar S, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lin HL, Lombardi P, McCubrey JA.

Adv Biol Regul. 2019 Aug;73. pii: S2212-4926(19)30029-6. doi: 10.1016/j.jbior.2019.04.003. Epub 2019 Apr 21.

PMID:
31047842
4.

Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals.

Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Bueno-Silva B, de Alencar SM, Lombardi P, Mao W, Montalto G, Cervello M, Rakus D, Gizak A, Lin HL, Libra M, Akula SM, McCubrey JA.

Adv Biol Regul. 2019 May;72:22-40. doi: 10.1016/j.jbior.2019.03.002. Epub 2019 Mar 15.

PMID:
30898612
5.

Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids.

Proietti M, Agosti P, Lonati C, Corrao S, Perticone F, Mannucci PM, Nobili A, Harari S; REPOSI Investigators.

J Am Med Dir Assoc. 2019 Mar 6. pii: S1525-8610(19)30159-8. doi: 10.1016/j.jamda.2019.01.132. [Epub ahead of print]

PMID:
30852169
6.

Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study.

Patti AM, Nikolic D, Magan-Fernandez A, Giglio RV, Castellino G, Chianetta R, Citarrella R, Corrado E, Provenzano F, Provenzano V, Montalto G, Rizvi AA, Rizzo M.

Diabetes Res Clin Pract. 2019 Mar;149:163-169. doi: 10.1016/j.diabres.2019.02.006. Epub 2019 Feb 10.

PMID:
30759365
7.

Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.

Brouwer WP, Chan HL, Lampertico P, Hou J, Tangkijvanich P, Reesink HW, Zhang W, Mangia A, Tanwandee T, Montalto G, Simon K, Ormeci N, Chen L, Tabak F, Gunsar F, Flisiak R, Ferenci P, Akdogan M, Akyuz F, Hirankarn N, Jansen L, Wong Wai-Sun V, Soffredini R, Liang X, Chen S, Groothuismink ZM, Santoro R, Jaroszewicz J, Ozaras R, Kozbial K, Brahmania M, Xie Q, Chotiyaputta W, Xun Q, Pazgan-Simon M, Oztas E, Verhey E, Montanari NR, Sun J, Hansen BE, Boonstra A, Janssen H; GIANT-B Global Consortium.

Clin Infect Dis. 2019 Feb 2. doi: 10.1093/cid/ciz084. [Epub ahead of print]

PMID:
30715261
8.

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma.

Augello G, Emma MR, Cusimano A, Azzolina A, Mongiovì S, Puleio R, Cassata G, Gulino A, Belmonte B, Gramignoli R, Strom SC, McCubrey JA, Montalto G, Cervello M.

Int J Cancer. 2019 May 15;144(10):2613-2624. doi: 10.1002/ijc.31963. Epub 2018 Dec 24.

PMID:
30488605
9.

Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells.

Abrams SL, Follo MY, Steelman LS, Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Libra M, Murata RM, Rosalen PL, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lombardi P, McCubrey JA.

Adv Biol Regul. 2019 Jan;71:172-182. doi: 10.1016/j.jbior.2018.10.003. Epub 2018 Oct 17.

PMID:
30361003
10.

Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.

Mannucci PM, Nobili A, Pasina L; REPOSI Collaborators (REPOSI is the acronym of REgistro POliterapie SIMI, Società Italiana di Medicina Interna).

Intern Emerg Med. 2018 Dec;13(8):1191-1200. doi: 10.1007/s11739-018-1941-8. Epub 2018 Aug 31. Review.

PMID:
30171585
11.

Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.

Giannitrapani L, Granà W, Licata A, Schiavone C, Montalto G, Soresi M.

Med Princ Pract. 2018;27(5):466-471. doi: 10.1159/000492893. Epub 2018 Aug 14.

12.

Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study.

Novo G, Macaione F, Giannitrapani L, Minissale MG, Bonomo V, Indovina F, Petta S, Soresi M, Montalto G, Novo S, Craxi A, Licata A.

Aliment Pharmacol Ther. 2018 Oct;48(7):740-749. doi: 10.1111/apt.14934. Epub 2018 Aug 10.

PMID:
30095177
13.

Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals.

Abrams SL, Lertpiriyapong K, Yang LV, Martelli AM, Cocco L, Ratti S, Falasca M, Murata RM, Rosalen PL, Lombardi P, Libra M, Candido S, Montalto G, Cervello M, Steelman LS, McCubrey JA.

Adv Biol Regul. 2018 Aug;69:16-34. doi: 10.1016/j.jbior.2018.06.002. Epub 2018 Jun 28.

PMID:
29980405
14.

Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines.

Chappell WH, Candido S, Abrams SL, Russo S, Ove R, Martelli AM, Cocco L, Ramazzotti G, Cervello M, Montalto G, Steelman LS, Leng X, Arlinghaus RB, Libra M, McCubrey JA.

Adv Biol Regul. 2018 Aug;69:43-62. doi: 10.1016/j.jbior.2018.05.002. Epub 2018 May 18.

PMID:
29861174
15.

GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms.

Rizzo M, Nikolic D, Patti AM, Mannina C, Montalto G, McAdams BS, Rizvi AA, Cosentino F.

Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2814-2821. doi: 10.1016/j.bbadis.2018.05.012. Epub 2018 May 18. Review.

16.

Statins in liver disease: not only prevention of cardiovascular events.

Magan-Fernandez A, Rizzo M, Montalto G, Marchesini G.

Expert Rev Gastroenterol Hepatol. 2018 Aug;12(8):743-744. doi: 10.1080/17474124.2018.1477588. Epub 2018 May 24. Review. No abstract available.

PMID:
29768950
17.

Corrigendum to "poly (ADP-ribose) polymerase inhibition synergizes with the NF-κB inhibitor DHMEQ to kill hepatocellular carcinoma cells" [Biochim. Biophys. Acta 1853(12)(2015) 3224-3234].

Lampiasi N, Umezawa K, Montalto G, Cervello M.

Biochim Biophys Acta Mol Cell Res. 2018 Jul;1865(7):1023. doi: 10.1016/j.bbamcr.2018.04.004. Epub 2018 Apr 21. No abstract available.

18.

Serum lipoproteins are not associated with the severity of asthma.

Scaduto F, Giglio RV, Benfante A, Nikolic D, Montalto G, Rizzo M, Scichilone N.

Pulm Pharmacol Ther. 2018 Jun;50:57-61. doi: 10.1016/j.pupt.2018.04.001. Epub 2018 Apr 4.

PMID:
29626633
19.

Natural approaches in metabolic syndrome management.

Patti AM, Al-Rasadi K, Giglio RV, Nikolic D, Mannina C, Castellino G, Chianetta R, Banach M, Cicero AFG, Lippi G, Montalto G, Rizzo M, Toth PP.

Arch Med Sci. 2018 Mar;14(2):422-441. doi: 10.5114/aoms.2017.68717. Epub 2017 Jul 19.

20.

Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample.

Augello G, Balasus D, Fusilli C, Mazza T, Emma MR, Giannitrapani L, Agliastro R, Cervello M, Montalto G.

OMICS. 2018 Apr;22(4):274-282. doi: 10.1089/omi.2017.0215. Epub 2018 Mar 27.

PMID:
29584564

Supplemental Content

Loading ...
Support Center